CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that Monica Kraft, MD, professor and chair of the Department of Medicine and The Robert and Irene Flinn Endowed Chair of Medicine at the University of Arizona College of Medicine – Tucson, and deputy director of the UA Health Sciences Asthma and Airway Disease Research Center, will be honored as the Arizona Bioscience Researcher of the Year for her work on precision medicine therapies to treat severe asthma.
Continue reading→

Launched by C-Path and NORD through an FDA grant, the goal of the new platform is to accelerate the development of cures by addressing the need to better characterize rare diseases.Continue reading→

TEMPE, Ariz.–(BUSINESS WIRE)–INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to receive up to $5.4 Million over four years as part of the Defense Advanced Research Projects Agency (DARPA) contract worth up to $27.8 Million awarded to consortium led by the Icahn School of Medicine at Mount Sinai New York.Continue reading→

• Just released new results in the Journal of Alzheimer’s Disease indicate that in-home treatment with a bioengineered head device emitting electromagnetic waves reversed memory impairment of Alzheimer’s patients (AD)
• After two months of Transcranial Electromagnetic Treatment (TEMT), average memory decline in nearly all patients was reversed back to their better cognitive levels of one year earlier.
• Findings point to a potential breakthrough in AD treatment, with TEMT apparently effecting the Alzheimer’s disease process itself within brain cells

Continue reading→

CHANDLER, Ariz. — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that Martha A. Brumfield, PhD, Special Advisor to the CEO and past President and CEO at the Critical Path Institute (C-Path) will be honored as the Jon W. McGarity Arizona Bioscience Leader of the Year at the 2019 AZBio Awards on October 2, 2019, at the Phoenix Convention Center.

“You probably know someone who is waiting for a cure. Most of us do.  It can take over 15 years and a billion dollars or more to bring a new life-saving or life-changing treatment to the people who are waiting for it,” shared AZBio President and CEO Joan Koerber-Walker. “Throughout her career, Dr. Brumfield has worked to bring new, safe, and effective treatments to market for patients who are waiting.”Continue reading→

Kalos Therapeutics is developing a platform of drugs containing multiple arrays of natriuretic peptide which have demonstrated a broad spectrum of anti-tumor activity with negligible or no known adverse effects. Continue reading→

WASHINGTON – Arizona Senator Kyrsten Sinema today led a bipartisan letter from members of the Arizona Congressional Delegation urging Congressional leaders to permanently repeal the medical device tax. Sinema was joined on the letter by Senator Martha McSally and Representatives Tom O’Halleran (AZ-01), Ann Kirkpatrick (AZ-02), Paul Gosar (AZ-04), Andy Biggs (AZ-05), David Schweikert (AZ-06), Debbie Lesko (AZ-08), and Greg Stanton (AZ-09).Continue reading→

Deep within the subterranean confines of Building C—the latest addition to the Biodesign Institute at Arizona State University—a pathbreaking machine is quietly taking shape. Designed to unlock some of nature’s tiniest and most fleeting mysteries, the Compact X-ray Free Electron Laser (CXFEL) is the only instrument of its kind in the world.

The device is the brainchild of physicist William Graves, a passionate authority on massive, intricate machines for leading-edge science. For the past 30 years he has worked on the design and construction of particle accelerators. The CXFEL represents ASU’s bold attempt to dramatically reduce the size of such instruments, making them suitable for universities and medical institutions.Continue reading→